Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The restaging issue.

P Van Schil1

  • 1Department of Thoracic and Vascular Surgery, University Hospital of Antwerp, Wilrijkstraat 10, B-2650 Edegem, Antwerp, Belgium. paul.van.schil@uza.be

Lung Cancer (Amsterdam, Netherlands)
|November 13, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

Intrathymic parathyroid adenoma presenting with seizures.

Acta chirurgica Belgica·2013
Same author

Endarterectomy combined with retrograde stenting for tandem lesions of the carotid artery.

Acta chirurgica Belgica·2011
Same author

Spontaneous pneumothorax: remaining controversies.

Minerva chirurgica·2011
Same author

Paradigm shifts in lung cancer as defined in the new IASLC/ATS/ERS lung adenocarcinoma classification.

The European respiratory journal·2011
Same author

Restaging the mediastinum in non-small cell lung cancer after induction therapy: non-invasive versus invasive procedures.

Acta chirurgica Belgica·2011
Same journal

Corrigendum to "European experience on oncological outcomes of patients with early stage non-small cell lung cancer and any prior cancer following lobectomy or segmentectomy" [Lung Cancer J. 217 (2026) 109410].

Lung cancer (Amsterdam, Netherlands)·2026
Same journal

Proportion of lung cancer patients eligible for screening in France: Data from the KBP-2020-CPHG study.

Lung cancer (Amsterdam, Netherlands)·2026
Same journal

Prevalence and characteristics of NTRK fusions in 25,946 patients with non-small cell lung cancer.

Lung cancer (Amsterdam, Netherlands)·2026
Same journal

Prognostic impact of the 9th vs 8th TNM classification in small-cell lung cancer. a population-based study.

Lung cancer (Amsterdam, Netherlands)·2026
Same journal

Corrigendum to "European experience on oncological outcomes of patients with early-stage non-small cell lung cancer and any prior cancer following lobectomy or segmentectomy" Published in [Lung Cancer https://doi.org/10.1016/j.lungcan.2026.109410].

Lung cancer (Amsterdam, Netherlands)·2026
Same journal

Genome-wide copy number analysis identifies AKT as a novel therapeutic target in pleural mesothelioma.

Lung cancer (Amsterdam, Netherlands)·2026
See all related articles

Accurate restaging of mediastinal lymph nodes after neoadjuvant therapy is crucial. Mediastinoscopy offers 80% accuracy for assessing mediastinal response, aiding patient selection for surgery.

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Diagnostic Imaging

Background:

  • Persisting mediastinal lymph node involvement post-neoadjuvant therapy indicates a poor prognosis.
  • Accurate restaging is vital for treatment decisions and prognosis in these patients.

Purpose of the Study:

  • To evaluate the accuracy of different restaging methods for mediastinal lymph nodes after neoadjuvant therapy.
  • To determine the utility of mediastinoscopy in selecting patients for surgical resection.

Main Methods:

  • Review of imaging techniques including computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET).
  • Assessment of invasive staging methods, specifically remediastinoscopy.
  • Correlation of findings with surgical outcomes (thoracotomy).

Related Experiment Videos

Main Results:

  • CT, MRI, and PET have limited accuracy in predicting response in mediastinal lymph nodes.
  • Positron emission tomography (PET) is sensitive for primary tumors but not mediastinal nodes.
  • Remediastinoscopy demonstrates 80% accuracy in confirming mediastinal downstaging, aiding patient selection.

Conclusions:

  • Invasive staging, particularly remediastinoscopy, is necessary for precise assessment of mediastinal response.
  • Remediastinoscopy is a valuable tool for selecting patients who may benefit from subsequent thoracotomy.
  • Thoracotomy with complete resection remains the gold standard for determining overall pathologic response.